Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2010
12/01/2010CN101903403A CD19 binding agents and uses thereof
12/01/2010CN101903402A Humanized antibodies against TL1A
12/01/2010CN101903399A Clostridial toxin netb
12/01/2010CN101903398A Edible product having an immunostimulating effect
12/01/2010CN101903044A Antibodies specific for human hepcidin
12/01/2010CN101903043A Modified influenza virus
12/01/2010CN101903042A Fish vaccine
12/01/2010CN101903041A Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
12/01/2010CN101903040A Turkey herpesvirus vectored recombinant containing avian influenza genes
12/01/2010CN101899466A Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof
12/01/2010CN101899465A Recombinant J subgroup avian leucosis virus infective cloned plasmids and preparation method and application thereof
12/01/2010CN101899461A Fusion gene capable of encoding influenza A virus NP protein and M2e polypeptide
12/01/2010CN101899421A Recombinant baculovirus and construction method and application thereof
12/01/2010CN101899418A Avian influenza virus (AIV) as well as kit and vaccine used for detecting and preventing same
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899117A Streptavidin/interleukin 21 fusion protein
12/01/2010CN101899114A Antibodies against PD-1 and uses therefor
12/01/2010CN101899101A Synthetic polypeptide for researching influenza virus subunit vaccine
12/01/2010CN101899100A Anti-HIV-I (Human Immunodeficiency Virus-I) polypeptides as well as coding sequences and applications thereof
12/01/2010CN101897983A Monocyte-specific particulate delivery vehicle
12/01/2010CN101897969A Use of complement inhibitors in preparing medicines for preventing or treating tissure damage
12/01/2010CN101897966A Cynomorium songaricum immunological adjuvant and influenza vaccine comprising same
12/01/2010CN101897965A Hepatitis B virus dendritic cell therapeutic vaccine and preparation method thereof
12/01/2010CN101897964A Medicament for preventing autoimmune disease
12/01/2010CN101897963A Vaccine for hand-foot-and-mouth disease viruses
12/01/2010CN101897962A Method for constructing autoimmune recurrent abortion mouse model
12/01/2010CN101897961A Preparation method for B cell CD 22 extracellular inhibitive peptide fragment B2285 vaccines
12/01/2010CN101897960A hNgR-Fc fusion protein vaccine for promoting regeneration and functional recovery of central nerves
12/01/2010CN101386833B Recombinant bacterium of brucella abortus and use thereof
12/01/2010CN101386831B Recombinant bacterium of brucella abortus with immunity labeling and use thereof
12/01/2010CN101386830B Recombinant bacterium of brucella melitensis with immunity labeling and use thereof
12/01/2010CN101023099B Methods for treating bone cancer pain by administering a nerve growth factor antagonist
11/2010
11/30/2010US7842798 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s); vaccines
11/30/2010US7842797 Human CDR-grafted antibody and antibody fragment thereof
11/30/2010US7842795 Nucleic acids encoding a heme binding protein polypeptide
11/30/2010US7842790 Immunoglobulin fusion for use in treating eating disorders associated with tumor growth and therapeutics
11/30/2010US7842788 Metalloproteinase specific immunoglobulin for use in treatment and prevention of degradative diseases of connective tissue
11/30/2010US7842787 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
11/30/2010US7842784 Antagonizing bone morphogenetic protein activity; utilizing polypeptide comprising amino acids 22-452 of sequence 8; bone diseases, tissue regeneration, wound healing
11/30/2010US7842782 Heparanase-derived peptides for vaccination of tumor patients
11/30/2010US7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/30/2010US7842480 Protein fusion comprising transport domain for use in treatment and prevention of viral inection and cell proliferative disorders
11/30/2010US7842458 Amino acid sequences for use in diagnosis, prevention and detection of cancer
11/30/2010US7842310 Pharmaceutical compositions in particulate form
11/30/2010US7842299 administering to a patient infected with mycobacterium tuberculosis, a therapeutically effective amount of an isolated polypeptide ( a polypeptide covalently linked to a carrier); protective immune response
11/30/2010US7842298 Hepatitis virus for use in the diagnosis and prevention of viral diseases in birds and humans; polynucleotide consisting of the nucleotide sequence of the ORF2 gene of an avian hepatitis E virus or its complementary strand
11/30/2010US7842297 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient
11/30/2010US7842296 Sequences from Piscirickettsia salmonis
11/30/2010US7842295 Canine influenza virus and related compositions and methods of use
11/30/2010US7842294 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits
11/30/2010US7842293 Compositions and methods using anti-CS1 antibodies to treat multiple myeloma
11/30/2010US7842292 TACI (transmembrane activator or Calcium-Modulating Cyclophylin Ligand-interactor); used to suppress proliferation-inducing functions of BlyS (B-lymphocyte stimulator) and APRIL (a proliferation-inducing ligand); including non-Hodgkin's lymphoma
11/30/2010US7842290 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms
11/30/2010US7842289 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/30/2010CA2338093C Vaccines against escherichia coli o157 infection
11/30/2010CA2259595C Dna immunization against chlamydia infection
11/25/2010WO2010135749A1 Herpes simplex virus type2: compositions and methods for eliciting an immune response
11/25/2010WO2010135747A1 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
11/25/2010WO2010135704A2 Secretion-related bacterial proteins for nlrc4 stimulation
11/25/2010WO2010135662A2 Marker differentially expressed in cancer stem cells and methods of using same
11/25/2010WO2010135585A2 Engineered type iv pilin of clostridium difficile
11/25/2010WO2010135547A1 Antibodies directed to gpnmb and uses thereof
11/25/2010WO2010135495A2 Stable, spray dried, immunogenic, viral compositions
11/25/2010WO2010135054A2 Mutations in a toll-like receptor motif in the ns4b of classical swine fever virus skin brescia influences virulence in swine
11/25/2010WO2010134939A2 Mammalian genes involved in infection
11/25/2010WO2010134601A1 Peptide inducing xage-1b-specific immune reaction and utilization of same
11/25/2010WO2010134508A1 Antibody against antimalarial drug and monoclonal antibody, and method for constructing same
11/25/2010WO2010134305A1 Peptidic antigen that induces antibody recognizing three-dimensional structure of hiv and method for synthesizing same
11/25/2010WO2010134225A1 Method for detection of infection by pathogenic neisseria bacteria using partial sugar chain epitope, and vaccine against the bacteria
11/25/2010WO2010134094A1 Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva)
11/25/2010WO2010133761A1 Intravaginal delivery system comprising one or more therapeutically active substances capable of preventing and/or treating vaginal infections
11/25/2010WO2010133663A1 Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
11/25/2010WO2010133592A1 A method for keeping an immunogenic composition available for administration to an animal
11/25/2010WO2010132954A1 Method of treating periodontal disease by administering antagonists of par-2
11/25/2010WO2010132932A1 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
11/25/2010WO2010117760A3 Fusion proteins comprising canine fc portions
11/25/2010WO2010115046A3 Vaccine compositions and methods of use thereof
11/25/2010WO2010112657A3 Pharmaceutical compositions for treating metastasis
11/25/2010WO2010104949A3 Anti-bcma antibodies
11/25/2010WO2010102251A3 Il-17 binding proteins
11/25/2010WO2010091679A3 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22
11/25/2010WO2010085611A3 Mycoplasma gallisepticum formulation
11/25/2010WO2010083225A3 Targeted cryptosporidium biocides
11/25/2010WO2010081095A3 Methods and compositions for inhibiting hepatitis c virus replication
11/25/2010WO2010062143A9 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
11/25/2010WO2010048615A3 Human ebola virus species and compositions and methods thereof
11/25/2010WO2009137871A8 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/25/2010US20100298544 Cdr-grafted anti-tissue factor antibodies and methods of use thereof
11/25/2010US20100298414 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100298359 Gamma secretase modulators
11/25/2010US20100297730 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/25/2010US20100297245 Methods and compositions for oral administration of protein and peptide therapeutic agents
11/25/2010US20100297231 Preservation of bioactive materials by freeze dried foam
11/25/2010US20100297217 Isoprenoid compounds, their isolation and use
11/25/2010US20100297192 Use of microparticles for vaccines and the release of biologically active molecules
11/25/2010US20100297189 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
11/25/2010US20100297188 Allergens and allergoids from bee venom
1 ... 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 ... 1823